KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 62 filers reported holding KITE PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $89,415,000 | -8.6% | 1,994,083 | +13.9% | 0.02% | -20.0% |
| Q3 2016 | $97,823,000 | +18.1% | 1,751,216 | +5.7% | 0.02% | +11.1% |
| Q2 2016 | $82,840,000 | +19.6% | 1,656,795 | +9.9% | 0.02% | +12.5% |
| Q1 2016 | $69,242,000 | -14.6% | 1,508,215 | +14.6% | 0.02% | -15.8% |
| Q4 2015 | $81,074,000 | +8.0% | 1,315,703 | -2.4% | 0.02% | 0.0% |
| Q3 2015 | $75,081,000 | -1.3% | 1,348,437 | +8.1% | 0.02% | +5.6% |
| Q2 2015 | $76,038,000 | +83.0% | 1,247,132 | +73.1% | 0.02% | +80.0% |
| Q1 2015 | $41,562,000 | +4.9% | 720,562 | +4.9% | 0.01% | 0.0% |
| Q4 2014 | $39,623,000 | +625.2% | 687,063 | +258.4% | 0.01% | +400.0% |
| Q3 2014 | $5,464,000 | – | 191,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |